| Table III.8: Reported State Licensing or Registration Requirements for FDA-Registered Outsourcing Facilities, by Reporting State | |||||||
|---|---|---|---|---|---|---|---|
| Requires FDA-registered outsourcing facilities to be licensed or registered in state | Category of state license or registration | ||||||
| State | Yes | No | No response | Pharmacy | Wholesale distributor | Manufacturer | Outsourcing facility (licensed or registered by the state) |
| Alabama | ✓ | ✓ | ✓ | ✓ | |||
| Arizona | ✓ | ✓ | |||||
| Arkansas | ✓ | ✓ | ✓ | ✓ | |||
| California | ✓ | ✓a | |||||
| Colorado | ✓ | ||||||
| Connecticut | ✓ | ||||||
| Delaware | ✓ | ✓ | ✓ | ||||
| District of Columbia | ✓ | ✓ | ✓ | ||||
| Florida | ✓ | ✓ | ✓ | ||||
| Georgia | ✓ | ✓ | ✓ | ✓ | |||
| Guam | ✓ | ||||||
| Hawaii | ✓ | ✓ | |||||
| Idaho | ✓ | ✓ | |||||
| Illinois | ✓ | ✓ | ✓ | ||||
| Iowa | ✓ | ✓ | ✓ | ||||
| Kansas | ✓ | ✓ | ✓ | ||||
| Kentucky | ✓ | ✓ | ✓ | ||||
| Louisiana | ✓ | ✓ | ✓ | ||||
| Maine | ✓ | ||||||
| Maryland | ✓ | ||||||
| Massachusetts | ✓ | ||||||
| Michigan | ✓ | ✓ | |||||
| Minnesota | ✓ | ✓ | |||||
| Mississippi | ✓ | ✓ | |||||
| Missouri | ✓ | ✓ | |||||
| Montana | ✓ | ✓ | ✓ | ||||
| Nebraska | ✓ | ✓ | ✓ | ||||
| Nevada | ✓ | ✓ | |||||
| New Hampshire | ✓ | ✓ | ✓ | ||||
| New Jersey | ✓ | ||||||
| New Mexico | ✓ | ✓ | |||||
| New York | ✓ | ✓ | |||||
| North Carolina | ✓ | ✓ | |||||
| North Dakota | ✓ | ✓ | ✓ | ||||
| Ohio | ✓ | ✓ | |||||
| Oklahoma | ✓ | ✓ | |||||
| Oregon | ✓ | ✓ | ✓ | ||||
| Pennsylvania | ✓ | ✓ | ✓ | ✓ | |||
| Rhode Island | ✓ | ||||||
| South Carolina | ✓ | ✓ | ✓ | ||||
| South Dakota | ✓ | ✓ | |||||
| Tennessee | ✓ | ✓ | |||||
| Texas | ✓ | ✓ | |||||
| Utah | ✓ | ✓ | |||||
| Vermont | ✓ | ✓ | |||||
| Virginia | ✓ | ✓ | |||||
| Washington | ✓ | ||||||
| West Virginia | ✓ | ✓ | |||||
| Wisconsin | ✓ | ||||||
| Wyoming | ✓ | ||||||
| Source: GAO survey of state pharmacy regulatory bodies, survey question 16. | GAO-17-363SP |
| Notes: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey. |
| aThis state reported requiring Food and Drug Administration (FDA) registered outsourcing facilities to be licensed as sterile compounding pharmacies. |